Vedana Therapeutics is a clinical-stage biotechnology company developing next-generation medicines for migraine prevention. Founded by biotech investor Anurag Agarwal and antibody-development veteran Leon Garcia, the company emerged from stealth in June 2026 with a $46 million Series A co-led by Westlake BioPartners and Canaan Partners, with… - View it on GitHub